Scant Worry Over PDL Patent Challenges
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm forges ahead with plans to split off biotech operations.
You may also be interested in...
Trubion Finds Kindred Spirit in Facet For Co-Development And Commercialization
Recently launched spinout from PDL BioPharma pays $20 million upfront to Trubion for chronic lymphocytic leukemia candidate.
Trubion Finds Kindred Spirit in Facet For Co-Development And Commercialization
Recently launched spinout from PDL BioPharma pays $20 million upfront to Trubion for chronic lymphocytic leukemia candidate.
UCB Wins FDA Nod For Cimzia In Crohn’s
Application is pending in rheumatoid arthritis, too.